Literature DB >> 30286823

Sepsis: An Update on Current Practices in Diagnosis and Management.

Snigdha Jain1.   

Abstract

Despite several advancements in care over the last few decades, sepsis continues to carry a high morbidity and mortality burden in the United States. With its varied presentations, cases of sepsis are likely to be encountered by general practitioners in both inpatient and outpatient settings. In the recent years, there has been much debate about the appropriate criteria to diagnose patients with sepsis with a concurrent change in management guidelines. This article reviews definitions, diagnosis and treatment guidelines in current practice in the management of patients with sepsis.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Infection; Sepsis; Sequential organ failure assessment; Severe sepsis

Mesh:

Year:  2018        PMID: 30286823     DOI: 10.1016/j.amjms.2018.06.012

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  14 in total

1.  Correlation of small nucleolar RNA host gene 16 with acute respiratory distress syndrome occurrence and prognosis in sepsis patients.

Authors:  Chengju Zhang; Qinghe Huang; Fuyun He
Journal:  J Clin Lab Anal       Date:  2022-05-27       Impact factor: 3.124

2.  For Patients With Acute PJI Treated With Debridement, Antibiotics, and Implant Retention, What Factors Are Associated With Systemic Sepsis and Recurrent or Persistent Infection in Septic Patients?

Authors:  Leanne Ludwick; Marcelo Siqueira; Noam Shohat; Matthew B Sherman; Sydney Streicher; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2022-04-14       Impact factor: 4.755

3.  Exhaled breath condensate biomarkers in critically ill, mechanically ventilated patients.

Authors:  Michael D Davis; Brett R Winters; Michael C Madden; Joachim D Pleil; Curtis N Sessler; M Ariel Geer Wallace; Cavin K Ward-Caviness; Alison J Montpetit
Journal:  J Breath Res       Date:  2020-11-12       Impact factor: 3.262

4.  Baicalin attenuates LPS-induced alveolar type II epithelial cell A549 injury by attenuation of the FSTL1 signaling pathway via increasing miR-200b-3p expression.

Authors:  Xin-Ya Duan; Yang Sun; Zhu-Feng Zhao; Yao-Qing Shi; Xun-Yan Ma; Li Tao; Ming-Wei Liu
Journal:  Innate Immun       Date:  2021-05-18       Impact factor: 2.680

5.  circSTRN3 aggravates sepsis-induced acute kidney injury by regulating miR-578/ toll like receptor 4 axis.

Authors:  Qiuying Gao; Yan Zheng; Hui Wang; Limin Hou; Xingxing Hu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

6.  Toxoplasma gondii GRA9 Regulates the Activation of NLRP3 Inflammasome to Exert Anti-Septic Effects in Mice.

Authors:  Jae-Sung Kim; Seok-Jun Mun; Euni Cho; Donggyu Kim; Wooic Son; Hye-In Jeon; Hyo Keun Kim; Kiseok Jang; Chul-Su Yang
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

Review 7.  Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets.

Authors:  Yupei Li; Dingyuan Wan; Xinyao Luo; Tao Song; Yiran Wang; Qiao Yu; Luojia Jiang; Ruoxi Liao; Weifeng Zhao; Baihai Su
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

8.  lncRNA GMDS‑AS1 upregulates IL‑6, TNF‑α and IL‑1β, and induces apoptosis in human monocytic THP‑1 cells via miR‑96‑5p/caspase 2 signaling.

Authors:  Lei Jiang; Jinghui Li
Journal:  Mol Med Rep       Date:  2022-01-04       Impact factor: 2.952

9.  Gastrodin alleviates inflammatory injury of cardiomyocytes in septic shock mice via inhibiting NLRP3 expression.

Authors:  Feifei Shao; Lingmin Zhou; Yu Zhang; Hongping Chen; Yu Zhang; Zhihui Guan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-06-09       Impact factor: 2.416

10.  Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation.

Authors:  Tiago Carvalheiro; Samuel Garcia; M Inês Pascoal Ramos; Barbara Giovannone; Timothy R D J Radstake; Wioleta Marut; Linde Meyaard
Journal:  Front Immunol       Date:  2020-08-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.